insulin glargine U300
Selected indexed studies
- rDNA insulin glargine U300 - a critical appraisal. (Diabetes Metab Syndr Obes, 2016) [PMID:27980431]
- Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus. (J Feline Med Surg, 2022) [PMID:34009061]
- Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes. (Expert Opin Drug Metab Toxicol, 2016) [PMID:27710135]
_Worker-drafted node — pending editorial review._
Connections
insulin glargine U300 is a side effect of
Sources
- rDNA insulin glargine U300 - a critical appraisal. (2016) pubmed
- Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus. (2022) pubmed
- Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes. (2016) pubmed
- U300 Insulin Glargine: A Novel Basal Insulin for Type 1 and Type 2 Diabetes. (2015) pubmed
- [New Insulins for Type 1 Diabetes treatment]. (2023) pubmed
- Safety, efficacy, and cost-effectiveness of insulin degludec U100 versus insulin glargine U300 in adults with type 1 diabetes: a systematic review and indirect treatment comparison. (2022) pubmed
- AUGMENTed Real-World Data Enhances Comparative Efficacy Between Once-Weekly Insulin Icodec with Dosing Guide App Versus Once-Daily Insulin Glargine U300 in Insulin-Naive Type 2 Diabetes. (2025) pubmed
- Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial. (2023) pubmed
- Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial. (2020) pubmed
- Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study. (2024) pubmed